These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Drug-induced nephropathy: our recent clinical experience. Omata M; Kikuchi M; Higuchi C; Sanaka S; Takuma T; Sugino N; Mori Y Dev Toxicol Environ Sci; 1986; 14():15-20. PubMed ID: 3104006 [No Abstract] [Full Text] [Related]
26. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin. Murgo AJ Am J Kidney Dis; 1987 Mar; 9(3):241. PubMed ID: 3826074 [No Abstract] [Full Text] [Related]
27. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. Cantrell JE; Phillips TM; Schein PS J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162 [TBL] [Abstract][Full Text] [Related]
29. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases]. Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482 [TBL] [Abstract][Full Text] [Related]
30. Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug. Verweij J; van der Burg ME; Pinedo HM Radiother Oncol; 1987 Jan; 8(1):33-41. PubMed ID: 3101142 [TBL] [Abstract][Full Text] [Related]
32. [Pneumo-renal syndrome with thrombotic microangiopathy after treatment with mitomycin]. Larregain Fournier D; Arlet P; Durand D; Fournier D; Le Tallec Y Presse Med; 1985 Apr; 14(15):842. PubMed ID: 3158910 [No Abstract] [Full Text] [Related]
33. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management]. Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566 [TBL] [Abstract][Full Text] [Related]
34. Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen. Ellis PA; Luckitt J; Treleaven J; Smith IE Clin Oncol (R Coll Radiol); 1996; 8(6):402-3. PubMed ID: 8973862 [No Abstract] [Full Text] [Related]
36. [Three cases of drug-induced hemolytic uremic syndrome]. Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831 [TBL] [Abstract][Full Text] [Related]
37. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Sheldon R; Slaughter D Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244 [TBL] [Abstract][Full Text] [Related]
38. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Giroux L; Bettez P; Giroux L Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715 [TBL] [Abstract][Full Text] [Related]
39. Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat. Cattell V Am J Pathol; 1985 Oct; 121(1):88-95. PubMed ID: 3876775 [TBL] [Abstract][Full Text] [Related]
40. A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome. Montes A; Powles TJ; O'Brien ME; Ashley SE; Luckit J; Treleaven J Eur J Cancer; 1993; 29A(13):1854-7. PubMed ID: 8260241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]